Conference Coverage
Conference Coverage
Standard-dose radiation bests high-dose radiation in advanced NSCLC
Major finding: Patients with stage-III non–small cell lung cancer who received high-dose radiation had a 56% greater risk of death than those on a...
Conference Coverage
Marijuana habit not linked to lung cancer
Major finding: People who habitually smoked marijuana were no more likely to develop lung cancer than those who didn’t, whether or not they also...
Conference Coverage
Prenatal exposure to air pollution boosts childhood cancer risk
Major finding: Children exposed prenatally to high levels of motor vehicle exhaust were 19% more likely to develop bilateral retinoblastoma and 17...
Conference Coverage
One in four melanoma patients shun sunscreen
Major finding: About 27% of melanoma survivors reported never wearing sunscreen, and 2% reported using a tanning bed.Data source: A database...
Conference Coverage
Mammography screening at 75 may have value
Major finding: Women aged 75 years and older were 3 times more likely to die from breast cancer if they went 5 or more years between mammograms,...
Conference Coverage
New data improve characterization of pediatric melanoma
Conference Coverage
MVAC plus cystectomy boosts bladder cancer survival
Major finding: Overall survival was better with MVAC plus radical cystectomy (median, 102 months) than with radical cystectomy alone, (median, 81...
Conference Coverage
VIDEO: Happy patients, happy physician practice
Conference Coverage
Gene profiling predicted responses to colorectal, pancreatic cancer treatment
Major finding: Gene expression patterns identified three subtypes of stage II or III colorectal cancer with different responses to 5-FU–based...
Conference Coverage
Add-on nab-paclitaxel extends survival in metastatic pancreatic cancer
Major Finding: Median overall survival in patients with metastatic pancreatic cancer increased from 6.7 months on gemcitabine to 8.5 months on nab...
Conference Coverage
Fewer acute GvHD cases after stem-cell transplant with vorinostat
Major Finding: The cumulative incidence of grade 2-4 acute graft-versus-host disease at day 100 after hematopoietic stem-cell transplant was 22%...